This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

Last Call! Online Registration Closes In:

  • 00
  • 00
  • 00
  • 00
6 - 8 June, 2023
Postillion Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Scientific Program Partner

Meeting agenda created in conjunction with The Antibody Society.

6 - 8 June, 2023
Postillion Hotel Amsterdam,
Digital Experience: All Sessions Live-streamed 6-8 June, 2023


Brand new for 2023: Dive into Antibody and VHH Discovery, Optimisation for Affinity, Active Biotherapeutics, Agonist Antibodies, Immunocytokines, Immunotherapy, T-Cell Engagers, ADCs, Machines Learning, the Fc Region, bispecifics and much more...

ConnectMe Platform Logins

Login details to the digital ConnectMe platform (for both digital and in-person attendees) have now been sent. If you have not received your login details, please contact Disha Koshal at

Connect with Global Antibody Experts & Get One-Step Closer to Your Next Therapeutic Break-Through

Dive into 9 critical hot topics in the industry, with the option to extend with a half-day post-conference workshop (Bispecific and Multispecific Antibodies)

  • Computational and Machine Learning-guided Antibody Engineering
  • Novel Antibody-Drug Conjugates
  • Fc & Albumin Engineering
  • T-Cell Engagers and Immunotherapy
  • Advances in Immunocytokines
  • Conditional/Targeted Activation
  • Agonist Antibodies
  • Bispecific and Multispecific Antibodies
  • Antibody Discovery, Engineering and Selection

About The Antibody Society

The Antibody Society is an international, non-profit trade association serving individuals and organizations involved in antibody-related research and development. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and commentary via the Society’s website, presentations and publications. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and standardization of next-generation sequencing of antibodies and T cell receptors. In addition, we engage with international agencies on matters of importance to the antibody community. 

Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics conferences. The scientific programs for the meetings are designed by our Meetings Committee. 

To learn more about The Antibody Society, meeting advisors and guest chairs please click here.

Connecting with Key Antibody Decision Makers

Put yourself in front of key decision makers within the antibody engineering landscape at Antibody Engineering & Therapeutics Europe.
We provide flexible, tailored solutions to optimize your investment. Below are some examples of how you can get involved at the event. There's no better place to network with core audiences and make lasting connections.

To learn more about available opportunities or to begin building your custom sponsorship package, please contact:

Blake Shuka: